-
- Winnie Luu
- School of Biotechnology and Biomolecular Sciences The University of New South Wales NSW Australia
-
- Laura J. Sharpe
- School of Biotechnology and Biomolecular Sciences The University of New South Wales NSW Australia
-
- Ingrid C. Gelissen
- Faculty of Pharmacy University of Sydney NSW Australia
-
- Andrew J. Brown
- School of Biotechnology and Biomolecular Sciences The University of New South Wales NSW Australia
抄録
<jats:title>Abstract</jats:title><jats:p>Cholesterol is a vital lipid and performs diverse functions on a whole body and cellular level. However, excess cellular cholesterol is toxic, and thus, elegant mechanisms have evolved to tightly regulate this important lipid. The regulation of cholesterol homeostasis is an area of intense research, and the role that signalling plays is gradually becoming more widely recognised. Cholesterol homeostasis is achieved through intricate mechanisms involving synthesis, uptake, and efflux. Although there is a large body of work elucidating these cholesterol‐related pathways, less is known about the role of signalling in these processes. Here, we discuss the variety of ways that signalling impacts on these modes and levels of cholesterol homeostasis, including transcriptional regulation. Most work thus far has investigated the role of kinases in cholesterol efflux (especially on ATP‐binding cassette transporter A1, ABCA1), and therefore constitutes a major focus of this review. We also indicate further avenues to explore in the area of signalling in cellular cholesterol homeostasis. © 2013 IUBMB Life, 65(8):675–684, 2013</jats:p>
収録刊行物
-
- IUBMB Life
-
IUBMB Life 65 (8), 675-684, 2013-07-11
Wiley
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1360574096004951296
-
- DOI
- 10.1002/iub.1182
-
- ISSN
- 15216551
- 15216543
-
- データソース種別
-
- Crossref